Displaying items 13-24 of 101
» View wsbtradio.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
•
Next >
-
HIV linked to higher chance of heart attack
ReutersNEW YORK (Reuters Health) - People with HIV are almost 50 percent more likely to have a heart attack than those who aren't infected with the virus - even after taking into account their other health risks, according to a new study. Researchers aren't...Tags: Heart Disease, Diabetes, University of Pittsburgh, Education, Science and Technology
-
Abbvie says Chief Scientific Officer John Leonard to retire
ReutersMay 10 (Reuters) - AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of naming a successor, the pharmaceutical company said in a regulatory filing on Friday. Chief Scientific Officer John M....Tags: Pharmaceuticals, Chemical Industry, Science, Science and Technology, Humira (drug)
-
Muchos estadounidenses no se realizan el examen adecuado para la hepatitis C: CDC
ReutersPor Julie Steenhuysen NUEVA YORK (Reuters) - Funcionarios de salud pública de Estados Unidos informaron que sólo la mitad de la población que alguna vez estuvo infectada con el virus de la hepatitis C se realizó la prueba de detección adecuada...Tags: U.S. Centers for Disease Control and Prevention, Viral Diseases and Infections, Disease Prevention, Diseases and Illnesses
-
Many with hepatitis C don't get needed follow-up tests, CDC says
Half of all patients who have tested positive for hepatitis C have not had follow-up testing to see if they are still infected, according to the Centers for Disease Control and Prevention. That means many people are living with the disease and not...
Tags: Medical Procedures and Tests, Liver Cancer, U.S. Centers for Disease Control and Prevention, Cirrhosis, Hepatitis
-
Many in U.S. don't get proper testing for hepatitis C- CDC
ReutersBy Julie Steenhuysen NEW YORK, May 8 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, according to U.S. health officials. Proper testing is a two-...Tags: Medical Procedures and Tests, Drugs and Medicines, Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Liver Cancer
-
REUTERS SUMMIT-Biotech firms evolve from targets to acquirers
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Skyrocketing valuations quash talks * With financing available, many biotechs go it alone * Bankers expect steady flow of $1 bln to $5 bln pharma deals By...Tags: Technology, Macular Degeneration, Biogen Idec Incorporated, Biotechnology, Mergers, Acquisitions and Takeovers
-
FDA fast tracks AbbVie hepatitis C drug
Tribune reporterAbbVie said Monday that its new hepatitis C drug regimen has been given a breakthrough therapy designation by the Food and Drug Administration, putting it on the fast track for potential approval in the United States. A breakthrough therapy...Tags: Food and Drug Administration, Vaccines, Hepatitis, Diseases and Illnesses, Trials
-
Additional question from Dr. Christopher Prince interview
Is Michigan’s law effective? The law has become more specific giving more definitions and clarifying explanations of its intent. The State has a list of approved diagnoses, which is to be expanded yearly, and conditions approved for the use of...Tags: Crime, Law and Justice, Health Treatments, Judges, Multiple Sclerosis, Medical Marijuana Therapy
-
International consortium releases hepatitis C data
Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...Tags: Food and Drug Administration, Education, Health and Safety at School, Health Organizations, Financial Aid
-
Humira sales propel AbbVie in 1Q
Tribune staff reporterIn its first quarter as an independent, publicly traded company, AbbVie Inc. said net income rose 9.6 percent, to $968 million, or 60 cents a share, from $883 million, or 56 cents a share, a year earlier when the company was still a part of Abbott...Tags: Corporate Officers, Abbott Laboratories, Drugs and Medicines, Science and Technology, Rheumatoid Arthritis
-
Vertex posts quarterly loss as hepatitis C drug sales fall
ReutersApril 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday reported a fourth successive quarterly loss as sales of its hepatitis C drug, Incivek, continued to plunge, but the biotechnology company raised its forecast for sales of a cystic fibrosis drug...Tags: Chemical Industry, Biotechnology, Science and Technology, Biotechnology Industry, Vertex Pharmaceuticals Incorporated
-
Bristol-Myers Squibb sales disappoint, shares fall
Reuters(Reuters) - Bristol-Myers Squibb reported disappointing first-quarter sales, prompting a drop in shares that have risen sharply this year on enthusiasm for its lineup of promising experimental drugs. The company on Thursday said sales plunged 27...Tags: Diabetes, Warfarin (drug), Morningstar Incorporated, Drugs and Medicines, Avapro (drug)
Mar 5, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 8, 2013
|Story| Los Angeles Times
May 8, 2013
|Story| Reuters
May 7, 2013
|Story| Reuters
May 6, 2013
|Story| Chicago Tribune
May 4, 2013
|Story| South Bend Tribune
May 2, 2013
|Story| South Florida Sun-Sentinel
Apr 26, 2013
|Story| Chicago Tribune
Apr 30, 2013
|Story| Reuters
Apr 25, 2013
|Story| Reuters
Original site for Hepatitis C topic gallery.